semaglutide fatty liver disease might be a key for breaking the vicious cycle of metabolically associated spectrum? Semaglutide for Fatty Liver Treatment

Individuals and healthcare professionals are encouraged to explore the evolving landscape of GLP-1 agonists as part of customized treatment plans for bipolar disorder

Disrupted peripheral lipid metabolism elevates circulating FFAs, which propagate neuroinflammation via BBB compromise

Nonetheless, studies have shown that Hes1 inactivation is not sufficient to induce mucus production

The Keap 1-Nrf 2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis

In this context, GLP-1 agonists represent a potentially valuable tool within a multimodal treatment approach, particularly for patients who have not achieved adequate weight loss through lifestyle modification alone